Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Acta Biochimica Polonica|August 21, 2010
Suppressor of cytokine signaling and accelerated atherosclerosis in kidney diseaseJoanna Wesoly, Krzysztof Sikorski, Chien-Kuo Lee, et al.
Scientific Data|April 1, 2022
SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applicationsMartyna Plens-Gałąska, Tomasz Woźniak, Joanna Wesoły, et al.
Cytokine & Growth Factor Reviews|July 15, 2011
STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular diseaseKrzysztof Sikorski, Anna Czerwoniec, Janusz M Bujnicki, et al.
Oncotarget|May 12, 2016
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseMalgorzata Szelag, Anna Piaszyk-Borychowska, Martyna Plens-Galaska, et al.
International Journal of Molecular Sciences|June 25, 2020
ESR Method in Monitoring of Nanoparticle Endocytosis in Cancer CellsRyszard Krzyminiewski, Bernadeta Dobosz, Bart Krist, et al.
European Journal of Pharmacology|December 2, 2008
Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modalityM Mehdi Rastmanesh, Branko Braam, Jaap A Joles, et al.
European Journal of Pharmacology|November 12, 2013
In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificityMalgorzata Szelag, Krzysztof Sikorski, Anna Czerwoniec, et al.
Cytokine & Growth Factor Reviews|April 8, 2016
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responsesKatarzyna Blaszczyk, Hanna Nowicka, Kaja Kostyrko, et al.
Frontiers in Immunology|July 3, 2025
Integrative multi-omics analysis of IFNγ-induced macrophages and atherosclerotic plaques reveals macrophage-dependent STAT1-driven transcription in atherosclerosisMahdi Eskandarian Boroujeni, Natalia Lopacinska, Aleksandra Antonczyk, et al.
European Journal of Pharmacology|July 29, 2008
Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney diseaseM Mehdi Rastmanesh, Hans A R Bluyssen, Jaap A Joles, et al.
Pageof 5